| Literature DB >> 33513350 |
Mai Luo1, Jessica N Spradlin1, Lydia Boike1, Bingqi Tong1, Scott M Brittain2, Jeffrey M McKenna2, John A Tallarico2, Markus Schirle2, Thomas J Maimone3, Daniel K Nomura4.
Abstract
The translation of functionally active natural products into fully synthetic small-molecule mimetics has remained an important process in medicinal chemistry. We recently discovered that the terpene natural product nimbolide can be utilized as a covalent recruiter of the E3 ubiquitin ligase RNF114 for use in targeted protein degradation-a powerful therapeutic modality within modern-day drug discovery. Using activity-based protein profiling-enabled covalent ligand-screening approaches, here we report the discovery of fully synthetic RNF114-based recruiter molecules that can also be exploited for PROTAC applications, and demonstrate their utility in degrading therapeutically relevant targets, such as BRD4 and BCR-ABL, in cells. The identification of simple and easily manipulated drug-like scaffolds that can mimic the function of a complex natural product is beneficial in further expanding the toolbox of E3 ligase recruiters, an area of great importance in drug discovery and chemical biology.Entities:
Keywords: PROTAC; RNF114; chemoproteomics; covalent ligand; cysteine; targeted protein degradation
Mesh:
Substances:
Year: 2021 PMID: 33513350 PMCID: PMC8052289 DOI: 10.1016/j.chembiol.2021.01.005
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116